Methods of staining target chromosomal DNA employing high complexity nucleic acid probes

• US 7,115,709 B1
• Filed: 06/07/1995
• Issued: 10/03/2006
• Est. Priority Date: 01/16/1986
• Status: Expired due to Term

• Current Assignee: Regents of the University of California (University of California)
• Original Assignee: Regents of the University of California (University of California)
• Inventors: Gray, Joe W., Kallioniemi, Ol'li-Pekka, Sakamoto, Masaru, Pinkel, Daniel, Kallioniemi, Anne
• Primary Examiner(s): Marschel, Ardin H.
• Application Number:
  US08/487,701
• Time in Patent Office: 4,136 Days
• Field of Search: 530/333, 435/6, 435/810, 436/501, 536/23.1, 536/24.7, 536/24.3, 536/33, 935/77, 935/78
• US Class Current: 530/333
• CPC Class Codes: C12Q 1/6827 for detection of mutation or polymorphism
• CPC Class Codes: C12Q 1/6841 In situ hybridisation
• CPC Class Codes: C12Q 1/6876 Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
• CPC Class Codes: C12Q 1/6879 for sex determination
• CPC Class Codes: C12Q 1/6886 for cancer immunoassay for cancer G01N33/574
• CPC Class Codes: C12Q 2525/151 repeat or repeated sequences, e.g. VNTR, microsatellite, concatemer
• CPC Class Codes: C12Q 2563/107 fluorescence
• CPC Class Codes: C12Q 2563/131 the label being a member of a cognate binding pair, i.e. extends to antibodies, haptens, avidin

Abstract

Methods and compositions for staining based upon nucleic acid sequence that employ nucleic acid probes are provided. Said methods produce staining patterns that can be tailored for specific cytogenetic analyses. Said probes are appropriate for in situ hybridization and stain both interphase and metaphase chromosomal material with reliable signals. The nucleic acid probes are typically of a complexity greater than 50 kb, the complexity depending upon the cytogenetic application. Methods and reagents are provided for the detection of genetic rearrangements. Probes and test kits are provided for use in detecting genetic rearrangements, particularly for use in tumor cytogenetics, in the detection of disease related loci, specifically cancer, such as chronic myelogenous leukemia (CML), retinoblastoma, ovarian and uterine cancers, and for biological dosimetry. Methods and reagents are described for cytogenetic research, for the differentiation of cytogenetically similar but genetically different diseases, and for many prognostic and diagnostic applications.

Claims

1. A method of staining target chromosomal material comprising:

(a) providing at least one labeled nucleic acid probe having a complexity greater than about 40 kb, which labeled nucleic acid probe comprises fragments which are substantially complementary to unique nucleic acid segments within the chromosomal material for which detection is desired, and providing blocking nucleic acid that comprises fragments which are substantially complementary to repetitive segments in the labeled nucleic acid; and

(b) employing said labeled nucleic acid probe, blocking nucleic acid, and chromosomal DNA in in situ hybridization so that labeled repetitive segments, if present, are substantially blocked from binding to the chromosomal DNA, while hybridization of unique segments within the labeled nucleic acid probe to the chromosomal DNA is allowed, wherein blocking of the labeled repetitive segments is sufficient to permit detection of hybridized labeled nucleic acid containing unique segments, and wherein the chromosomal DNA is present in a morphologically identifiable chromosome or cell nucleus during the in situ hybridization.

2. The method of claim 1, wherein the chromosomal DNA is present in a morphologically identifiable chromosome.

3. The method of claim 1, wherein the chromosomal material is from a fetal cell.

4. The method of claim 2, further comprising the step of separating the fetal cell from maternal blood.

5. The method of claim 1, wherein the labeled nucleic acid probe comprises heterogeneous mixtures of labeled nucleic acid fragments, wherein the nucleic acid fragments are substantially complementary to sites on the targeted chromosomal material and are substantially free of nucleic acid sequences having a hybridization capacity to sites on chromosomal material that is not targeted.

6. The method of claim 1, wherein the labeled nucleic acid probe comprises fragments which are designed to allow detection of extra or missing chromosomes.

7. The method of claim 1, wherein the labeled nucleic acid probe comprises fragments which are designed to allow detection of extra or missing portions of a chromosome.

8. The method of claim 1, wherein the labeled nucleic acid probe comprises fragments which are designed to allow detection of chromosomal rearrangement.

9. The method of claim 8, wherein the chromosomal rearrangement is an inversion.

10. The method of claim 8, wherein the chromosomal rearrangement is an insertion.

11. The method of claim 8, wherein the chromosomal rearrangement is a translocation.

12. The method of claim 8, wherein the chromosomal rearrangement is an amplification.

13. The method of claim 8, wherein the chromosomal rearrangement is a deletion.

14. The method of claim 1, wherein the target chromosomal material is present in an interphase cell nucleus.

15. The method of claim 14, wherein the labeled nucleic acid has a complexity of between about 40 kb and 100 kb.

16. The method of claim 14, wherein the labeled nucleic acid has a complexity between about 50 kb and 400 kb.

17. The method of claim 1, wherein the labeled nucleic acid comprises fragments complementary to the total genomic complement of chromosomes.

18. The method of claim 1, wherein the labeled nucleic acid comprises fragments complementary to a single chromosome.

19. The method of claim 1, wherein the labeled nucleic acid comprises fragments complementary to a subset of chromosomes.

20. The method of claim 1, wherein the labeled nucleic acid comprises fragments complementary to a subregion of a single chromosome.

21. The method of claim 1, wherein the labeled nucleic acid is designed to allow detection of cancer.

22. The method of claim 1, further comprising removing from the labeled nucleic acid fragments which are substantially complementary to repetitive segments within the target chromosomal material.

23. A method of staining target interphase chromosomal DNA comprising:

(a) providing at least one labeled nucleic acid probe having a complexity greater than about 40 kb which labeled nucleic acid probe comprises fragments which are substantially complementary to unique nucleic acid segments within the chromosomal DNA for which detection is desired, wherein the nucleic acid probe is substantially free of repetitive segments which are complementary to repetitive segments in the target interphase chromosomal material; and

(b) employing said labeled nucleic acid probe and chromosomal DNA in in situ hybridization so that hybridization of unique segments within the labeled nucleic acid probe to the chromosomal DNA is allowed, and hybridized labeled nucleic acid containing unique segments are detected, and wherein the interphase chromosomal DNA is present in a morphologically identifiable cell nucleus during the in situ hybridization.

25. The method of claim 23, wherein the chromosomal material is from a fetal cell.

26. The method of claim 25, further comprising the step of separating the fetal cell from maternal blood.

27. The method of claim 23, wherein the labeled nucleic acid probe comprises heterogeneous mixtures of labeled nucleic acid fragments, wherein the nucleic acid fragments are substantially complementary to sites on the targeted chromosomal material and are substantially free of nucleic acid sequences having a hybridization capacity to sites on chromosomal material that is not targeted.

28. The method of claim 23, wherein the labeled nucleic acid probe comprises fragments which are designed to allow detection of extra or missing chromosomes.

29. The method of claim 23, wherein the labeled nucleic acid probe comprises fragments which are designed to allow detection of extra or missing portions of a chromosome.

30. The method of claim 23, wherein the labeled nucleic acid probe comprises fragments which are designed to allow detection of chromosomal rearrangement.

31. The method of claim 30, wherein the chromosomal rearrangement is an inversion.

32. The method of claim 30, wherein the chromosomal rearrangement is an insertion.

33. The method of claim 30, wherein the chromosomal rearrangement is a translocation.

34. The method of claim 30, wherein the chromosomal rearrangement is an amplification.

35. The method of claim 30, wherein the chromosomal rearrangement is a deletion.

36. The method of claim 23, wherein the labeled nucleic acid has a complexity of between about 40 kb and 100 kb.

37. The method of claim 23, wherein the labeled nucleic acid has a complexity between about 50 kb and 100 kb.

38. The method of claim 23, wherein the labeled nucleic acid comprises fragments complementary to the total genomic complement of chromosomes.

39. The method of claim 23, wherein the labeled nucleic acid comprises fragments complementary to a single chromosome.

40. The method of claim 23, wherein the labeled nucleic acid comprises fragments complementary to a subregion of a single chromosome.

41. The method of claim 23, wherein the labeled nucleic acid is designed to allow detection of cancer.

42. The method of claim 23, wherein the targeted chromosomal material is a genetic rearrangement associated with chromosome 21 in humans.

43. The method of claim 23, wherein fragments substantially complementary to repetitive segments in the target interphase chromosomal material are removed from the labeled nucleic acid probe.

44. The method of claim 23, wherein the complexity of the labeled nucleic acid probe is greater than about 200 kb.

24. A method of staining target interphase chromosomal DNA comprising:

providing at least one labeled nucleic acid probe having a complexity greater than about 40 kb which labeled nucleic acid probe comprises fragments which are substantially complementary to unique nucleic acid segments within the chromosomal DNA for which detection is desired, wherein the nucleic acid probe is substantially free of repetitive segments which are complementary to repetitive segments in the target interphase chromosomal material;

further comprising

providing blocking nucleic acid that comprises fragments which are substantially complementary to repetitive segments in the labeled nucleic acid probe and employing said labeled nucleic acid probe, blocking nucleic acid, and chromosomal DNA in in situ hybridization so that hybridization of unique segments within the labeled nucleic acid probe to the chromosomal DNA is allowed, labeled repetitive segments, if present, are substantially blocked from binding to the chromosomal DNA, and hybridized labeled nucleic acid containing unique segments are detected, and wherein the interphase chromosomal DNA is present in a morphologically identifiable cell nucleus during the in situ hybridization.

45. A method of staining target chromosomal material comprising:

(a) providing at least one labeled nucleic acid probe having a complexity greater than about 50 kb, which labeled nucleic acid probe comprises fragments which are substantially complementary to unique nucleic acid segments within the chromosomal material for which detection is desired, and providing blocking nucleic acid that comprises fragments which are substantially complementary to repetitive segments in the labeled nucleic acid; and

(b) employing said labeled nucleic acid probe, blocking nucleic acid, and chromosomal DNA in in situ hybridization so that labeled repetitive segments, if present, are substantially blocked from binding to the chromosomal DNA, while hybridization of unique segments within the labeled nucleic acid probe to the chromosomal DNA is allowed, wherein blocking of the labeled repetitive segments is sufficient to permit detection of hybridized labeled nucleic acid containing unique segments, and wherein the chromosomal DNA is present in a morphologically identifiable chromosome or cell nucleus during the in situ hybridization.

46. The method of claim 45, wherein the target chromosomal material is present in an interphase cell nucleus.

47. The method of claim 46, wherein the labeled nucleic acid has a complexity of between about 50 kb and 400 kb.

48. The method of claim 47, wherein the labeled nucleic acid has a complexity between about 50 kb and 100 kb.

49. A method of staining target interphase chromosomal DNA comprising:

(a) providing at least one labeled nucleic acid probe having a complexity greater than about 50 kb which labeled nucleic acid probe comprises fragments which are substantially complementary to unique nucleic acid segments within the chromosomal DNA for which detection is desired, wherein the nucleic acid probe is substantially free of repetitive segments which are complementary to repetitive segments in the target interphase chromosomal material; and

(b) employing said labeled nucleic acid probe and chromosomal DNA in in situ hybridization so that hybridization of unique segments within the labeled nucleic acid probe to the chromosomal DNA is allowed, and hybridized labeled nucleic acid containing unique segments are detected, and wherein the interphase chromosomal DNA is present in a morphologically identifiable cell nucleus during the in situ hybridization.

50. The method of claim 49, wherein the labeled nucleic acid has a complexity of between about 50 kb and 400 kb.

51. The method of claim 50, wherein the labeled nucleic acid has a complexity between about 50 kb and 100 kb.